| MeSH term | MeSH ID | Detail |
|---|---|---|
| Periodontitis | D010518 | 22 associated lipids |
| Gastrointestinal Diseases | D005767 | 20 associated lipids |
| Vomiting | D014839 | 21 associated lipids |
| Fever | D005334 | 35 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Toxoplasmosis | D014123 | 9 associated lipids |
| Toxoplasmosis, Congenital | D014125 | 2 associated lipids |
| Otitis Media with Effusion | D010034 | 9 associated lipids |
| Shock, Septic | D012772 | 11 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nash MM and Zaltzman JS | Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. | 1998 | Transplantation | pmid:9665078 |
| Dooley DP | Revisiting doxycycline. | 1998 | Arch. Intern. Med. | pmid:9665360 |
| Soepandi P et al. | The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. | 1998 | Respirology | pmid:9692520 |
| Fang X et al. | [Inhibitory activity of azithromycin on biofilm synthesis and synergism between azithromycin and fleroxacin on Pseudomonas aeruginosa in biofilms]. | 1998 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:11360505 |
| Mitrokhin SD et al. | [Susceptibility of community-acquired pneumonia pathogens to azithromycin]. | 1998 | Antibiot. Khimioter. | pmid:9606504 |
| Thornton AC et al. | Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial. | 1998 | J. Infect. Dis. | pmid:9607840 |
| Palomar R et al. | Effectiveness and safety of azithromycin on the treatment of cyclosporine-induced gingival overgrowth. | 1998 | Nephron | pmid:9609470 |
| Matlow A et al. | Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. | 1998 | Antimicrob. Agents Chemother. | pmid:9593171 |
| Kozyrskyj AL et al. | Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. | 1998 | JAMA | pmid:9624028 |
| Bowden FJ and Savage J | Azithromycin for the treatment of donovanosis. | 1998 | Sex Transm Infect | pmid:9634320 |
| Cremer J et al. | Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9707305 |
| GarcÃa Callejo FJ et al. | [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections]. | 1998 | Acta Otorrinolaringol Esp | pmid:9707742 |
| Kober MB and Mason BA | Colonization of the female genital tract by resistant Ureaplasma urealyticum treated successfully with azithromycin. | 1998 | Clin. Infect. Dis. | pmid:9709898 |
| Langtry HD and Balfour JA | Azithromycin. A review of its use in paediatric infectious diseases. | 1998 | Drugs | pmid:9711451 |
| Bianchi A et al. | Kinetics of Chlamydia trachomatis clearance in patients with azithromycin, as assessed by first void urine testing by PCR and transcription-mediated amplification. | 1998 | Sex Transm Dis | pmid:9713917 |
| Karpov OI et al. | [Comparative trial of 3-day azithromycin versus 10-day coamoxilav course efficacy in acute sinusitis]. | 1998 | Ter. Arkh. | pmid:9644751 |
| [6th München AIDS-Days. Azithromycin in HIV-associated opportunistic infections]. | 1998 | Internist (Berl) | pmid:9648000 | |
| Van Bambeke F et al. | Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin. | 1998 | J. Antimicrob. Chemother. | pmid:10052900 |
| Denis A and Agouridas C | Synthesis of 6-O-methyl-azithromycin and its ketolide analogue via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime. | 1998 | Bioorg. Med. Chem. Lett. | pmid:9873555 |
| den Hollander JG et al. | Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. | 1998 | Antimicrob. Agents Chemother. | pmid:9527789 |
| Nowicki M et al. | Partial regression of advanced cyclosporin-induced gingival hyperplasia after treatment with azithromycin. A case report. | 1998 | Ann. Transplant. | pmid:10234432 |
| Vcev A et al. | Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease. | 1998 | Acta Med Croatica | pmid:9988898 |
| Chey WD et al. | Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection. | 1998 | Aliment. Pharmacol. Ther. | pmid:9882036 |
| Trevisani L et al. | Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease. | 1998 | Aliment. Pharmacol. Ther. | pmid:9882037 |
| Gascón A et al. | Cryptosporidiosis in a haemodialysis patient with depressed CD4+ T cell count: successful treatment with azithromycin. | 1998 | Nephrol. Dial. Transplant. | pmid:9829506 |
| Tapsall JW et al. | Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. | 1998 | Sex Transm Dis | pmid:9858344 |
| Johnson DM et al. | Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia. | 1998 | J. Antimicrob. Chemother. | pmid:9818765 |
| Hoppe JE and Bryskier A | In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). | 1998 | Antimicrob. Agents Chemother. | pmid:9559823 |
| Karcioglu ZA et al. | Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels. | 1998 | Ophthalmology | pmid:9544640 |
| Mizutani S | [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis]. | 1998 | Kekkaku | pmid:9545702 |
| Walsh T et al. | Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. | 1998 | Lancet | pmid:9546505 |
| Hoge CW et al. | Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. | 1998 | Clin. Infect. Dis. | pmid:9502453 |
| Clancy CJ and Nguyen MH | The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis. | 1998 | J. Antimicrob. Chemother. | pmid:9511049 |
| Oldfield EC et al. | Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. | 1998 | Clin. Infect. Dis. | pmid:9524832 |
| Fuentes F et al. | Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. | 1998 | Antimicrob. Agents Chemother. | pmid:9527796 |
| Kashuba AD and Amsden GW | Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. | 1998 | Antimicrob. Agents Chemother. | pmid:9527816 |
| Miller SR et al. | Delayed cellulitis associated with conservative therapy for breast cancer. | 1998 | J Surg Oncol | pmid:9579371 |
| Scaglione F and Rossoni G | Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. | 1998 | J. Antimicrob. Chemother. | pmid:9579712 |
| Berry V et al. | Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. | 1998 | Antimicrob. Agents Chemother. | pmid:9835514 |
| Kemper CA et al. | Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. | 1998 | J. Infect. Dis. | pmid:9534963 |
| Jucglà A et al. | The use of azithromycin for cyclosporin-induced gingival overgrowth. | 1998 | Br. J. Dermatol. | pmid:9536254 |
| Lilley LL and Guanci R | Distraction delays a dose. | 1998 | Am J Nurs | pmid:9473978 |
| Hahn DL et al. | Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. | 1998 | Ann. Allergy Asthma Immunol. | pmid:9475566 |
| Dietz A et al. | [Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome)]. | 1998 | Laryngorhinootologie | pmid:9555706 |
| Levert H et al. | Azithromycin impact on neutrophil oxidative metabolism depends on exposure time. | 1998 | Inflammation | pmid:9561928 |
| Trevisani L et al. | A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. | 1998 | Am. J. Gastroenterol. | pmid:9517646 |
| Bowden FJ and Savage J | Donovanosis: treatment with azithromycin. | 1998 | Int J STD AIDS | pmid:9518024 |
| Champney WS and Burdine R | Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells. | 1998 | Microb. Drug Resist. | pmid:9818968 |
| Edelstein PH | Legionnaires' disease. | 1998 | N. Engl. J. Med. | pmid:9441231 |
| Bermudez LE et al. | Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy. | 1998 | Antimicrob. Agents Chemother. | pmid:9449283 |
| Roblin PM and Hammerschlag MR | Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. | 1998 | Antimicrob. Agents Chemother. | pmid:9449287 |
| Jaffé A et al. | Long-term azithromycin may improve lung function in children with cystic fibrosis. | 1998 | Lancet | pmid:9482305 |
| Seelis RE and Dohmen W | [Short-term (6 days) eradication of Helicobacter pylori infection in the practice of a health insurance physician]. | 1998 | Dtsch. Med. Wochenschr. | pmid:9487294 |
| Pontani D et al. | Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9758284 |
| Thalhammer F et al. | Azithromycin-related toxic effects of digitoxin. | 1998 | Br J Clin Pharmacol | pmid:9489601 |
| Wawer MJ et al. | A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. | 1998 | AIDS | pmid:9677171 |
| Goldstein EJ et al. | Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. | 1998 | Antimicrob. Agents Chemother. | pmid:9593139 |
| Spangler SK et al. | Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. | 1998 | Antimicrob. Agents Chemother. | pmid:9593160 |
| Turcinov T and Pepeljnjak S | Azithromycin potency determination: optimal conditions for microbiological diffusion method assay. | 1998 | J Pharm Biomed Anal | pmid:9682177 |
| Pankuch GA et al. | In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9797225 |
| Roblin PM and Hammerschlag MR | In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9624507 |
| Choi EK and Pai H | Azithromycin therapy for scrub typhus during pregnancy. | 1998 | Clin. Infect. Dis. | pmid:9868680 |
| Tabbara KF et al. | Ocular levels of azithromycin. | 1998 | Arch. Ophthalmol. | pmid:9869792 |
| Dagan R et al. | Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. | 1998 | Pediatr. Infect. Dis. J. | pmid:9779760 |
| Girgis N et al. | Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. | 1998 | Pediatr. Infect. Dis. J. | pmid:9779768 |
| Gruber F et al. | Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa. | 1998 | J Chemother | pmid:9876055 |
| Gaydos CA et al. | Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. | 1998 | J. Infect. Dis. | pmid:9466530 |
| Négrel AD and Mariotti SP | WHO alliance for the global elimination of blinding trachoma and the potential use of azithromycin. | 1998 | Int. J. Antimicrob. Agents | pmid:9916898 |
| Lacy MK et al. | Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae. | 1998 | Int. J. Antimicrob. Agents | pmid:9916901 |
| Cohen DA et al. | A school-based Chlamydia control program using DNA amplification technology. | 1998 | Pediatrics | pmid:9417165 |
| Fera MT et al. | Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. | 1998 | Int. J. Antimicrob. Agents | pmid:9916902 |
| Klausner JD et al. | Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. | 1998 | J. Infect. Dis. | pmid:9419183 |
| Jakob-Sölder B et al. | Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9923529 |
| Yanami J et al. | [Tumor neovascularization inhibiting and tumor proliferation and metastasis suppressing actions of 14-, 15-, and 16-member ring macrolides]. | 1998 | Jpn J Antibiot | pmid:9597489 |
| Inoue K et al. | [Inhibitory effects of macrolide antibiotics on infiltration and proliferation of lung cancer cell lines, A-549 and SBC-3]. | 1998 | Jpn J Antibiot | pmid:9597493 |
| Nakayama I et al. | [Transport of azithromycin into infected tissue observed by macro- and microautoradiography]. | 1998 | Jpn J Antibiot | pmid:9597509 |
| Dionisio D et al. | Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin. | 1998 | J. Clin. Pathol. | pmid:9602688 |
| Hillis SD et al. | Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. | 1998 | Sex Transm Dis | pmid:9437777 |
| Sánchez F et al. | [Treatment of pneumonia caused by Legionella with azithromycin]. | 1998 | Rev Esp Quimioter | pmid:9795300 |
| Bayoumi AM and Redelmeier DA | Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. | 1998 | AIDS | pmid:9727572 |
| Moyle GJ et al. | Once weekly azithromycin as prophylaxis against recurrence of non-tuberculous mycobacterial infections in HIV-1-positive individuals. | 1998 | AIDS | pmid:9727581 |
| Gray GC et al. | Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. | 1998 | Clin. Infect. Dis. | pmid:9455517 |
| Smith NH et al. | Combination drug therapy for cryptosporidiosis in AIDS. | 1998 | J. Infect. Dis. | pmid:9728569 |
| Andersen SL et al. | Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. | 1998 | Clin. Infect. Dis. | pmid:9455524 |
| Hammerschlag MR et al. | Treatment of neonatal chlamydial conjunctivitis with azithromycin. | 1998 | Pediatr. Infect. Dis. J. | pmid:9849993 |
| Chia JK et al. | Azithromycin for the treatment of cat-scratch disease. | 1998 | Clin. Infect. Dis. | pmid:9455538 |
| Raines DA et al. | Simultaneous high-performance liquid chromatography analysis of azithromycin and two of its metabolites in human tears and plasma. | 1998 | Ther Drug Monit | pmid:9853988 |
| Peterson J and Treadway G | Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. | 1998 | Clin. Infect. Dis. | pmid:9455579 |
| Alder JD et al. | Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. | 1998 | Antimicrob. Agents Chemother. | pmid:9736568 |
| Holmberg SD et al. | Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. | 1998 | JAMA | pmid:9459473 |
| Yeo AE et al. | Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum. | 1998 | Southeast Asian J. Trop. Med. Public Health | pmid:9740262 |
| Rajyaguru JM and Muszynski MJ | Sensitization of Burkholderia cepacia to antibiotics by cationic drugs. | 1998 | J. Antimicrob. Chemother. | pmid:9533472 |
| Mainardi JL et al. | Cat scratch disease due to Bartonella henselae serotype Marseille (Swiss cat) in a seronegative patient. | 1998 | J. Clin. Microbiol. | pmid:9742017 |
| Gruber F et al. | Treatment of confluent and reticulated papillomatosis with azithromycin. | 1998 | Clin. Exp. Dermatol. | pmid:9894368 |
| Aubert JD et al. | Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers. | 1998 | Pulm Pharmacol Ther | pmid:10101742 |
| Bauriedel G et al. | Azithromycin, Chlamydia pneumoniae, and intimal thickening. | 1998 | Circulation | pmid:9826328 |
| Ward TT et al. | Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. | 1998 | Clin. Infect. Dis. | pmid:9827282 |
| Carbon C | Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. | 1998 | Clin. Infect. Dis. | pmid:9675445 |
| Dimitrakov J et al. | A case of Chlamydia trachomatis infection in a renal allograft patient. | 1998 | Folia Med (Plovdiv) | pmid:10371799 |
| Borisov I | [A new therapeutic approach in the treatment of genital chlamydial infections. Azithromycin (Sumamed)]. | 1998 | Akush Ginekol (Sofiia) | pmid:10204275 |